BIT
PBYI icon

BlackRock Institutional Trust’s Puma Biotechnology PBYI Stock Holding History

BlackRock Institutional Trust’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$23.8M Buy
776,456
+136,519
+21% +$5.9M ﹤0.01% 1839
2016
Q3 		$42.9M Buy
639,937
+57,373
+10% +$2.9M 0.01% 1387
2016
Q2 		$17.4M Sell
582,564
-2,415
-0.4% -$75.5K ﹤0.01% 1939
2016
Q1 		$17.2M Buy
584,979
+14,132
+2% +$639K ﹤0.01% 1918
2015
Q4 		$44.8M Sell
570,847
-19,443
-3% -$1.53M 0.01% 1311
2015
Q3 		$44.5M Buy
590,290
+1,597
+0.3% +$151K 0.01% 1292
2015
Q2 		$68.7M Buy
588,693
+20,164
+4% +$3.65M 0.01% 1122
2015
Q1 		$134M Buy
568,529
+13,138
+2% +$2.81M 0.02% 752
2014
Q4 		$105M Buy
555,391
+1,981
+0.4% +$440K 0.02% 852
2014
Q3 		$132M Sell
553,410
-43,438
-7% -$8.92M 0.02% 702
2014
Q2 		$39.4M Buy
596,848
+29,241
+5% +$2.08M 0.01% 1482
2014
Q1 		$59.1M Buy
567,607
+85,403
+18% +$10M 0.01% 1174
2013
Q4 		$49.9M Buy
482,204
+179,790
+59% +$10.6M 0.01% 1257
2013
Q3 		$16.2M Buy
302,414
+44,589
+17% +$2.4M ﹤0.01% 2014
2013
Q2 		$11.4M Buy
+257,825
New +$9.09M ﹤0.01% 2226

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

BlackRock Institutional Trust's PBYI Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Puma Biotechnology (PBYI) stake by 21% in Q4 2016, buying an estimated $5.9M and bringing the position to 776,456 shares worth $23.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1839.

BlackRock Institutional Trust first reported a position in PBYI in Q2 2013 and has held it in 15 quarters since. The position peaked at $134M in Q1 2015. 128 funds tracked by Wall St. Rank hold PBYI as of Q4 2016.

  • BlackRock Institutional Trust held 776,456 shares of Puma Biotechnology worth $23.8M as of Q4 2016.
  • BlackRock Institutional Trust bought 136,519 Puma Biotechnology shares in Q4 2016, an estimated $5.9M.
  • Puma Biotechnology made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1839 holding.
  • BlackRock Institutional Trust first reported a position in Puma Biotechnology in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Puma Biotechnology position peaked at $134M in Q1 2015.
  • 128 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.